- Home
- BRBR vs LNTH Comparison
BRBR vs LNTH Comparison
Compare BRBR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBR
- LNTH
- Stock Information
- Founded
- BRBR 2019
- LNTH 1956
- Country
- BRBR United States
- LNTH United States
- Employees
- BRBR N/A
- LNTH N/A
- Industry
- BRBR Packaged Foods
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BRBR Consumer Staples
- LNTH Health Care
- Exchange
- BRBR Nasdaq
- LNTH Nasdaq
- Market Cap
- BRBR 8.8B
- LNTH 7.5B
- IPO Year
- BRBR 2019
- LNTH 2015
- Fundamental
- Price
- BRBR $75.12
- LNTH $101.32
- Analyst Decision
- BRBR Buy
- LNTH Strong Buy
- Analyst Count
- BRBR 17
- LNTH 6
- Target Price
- BRBR $78.88
- LNTH $129.83
- AVG Volume (30 Days)
- BRBR 1.3M
- LNTH 830.2K
- Earning Date
- BRBR 05-05-2025
- LNTH 05-01-2025
- Dividend Yield
- BRBR N/A
- LNTH N/A
- EPS Growth
- BRBR 72.45
- LNTH N/A
- EPS
- BRBR 2.12
- LNTH 4.36
- Revenue
- BRBR $2,098,700,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- BRBR $18.27
- LNTH $5.74
- Revenue Next Year
- BRBR $11.01
- LNTH $12.27
- P/E Ratio
- BRBR $35.43
- LNTH $23.24
- Revenue Growth
- BRBR 21.00
- LNTH 18.32
- 52 Week Low
- BRBR $48.06
- LNTH $61.47
- 52 Week High
- BRBR $80.67
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- BRBR 55.43
- LNTH 55.37
- Support Level
- BRBR $72.83
- LNTH $91.65
- Resistance Level
- BRBR $77.65
- LNTH $104.00
- Average True Range (ATR)
- BRBR 3.56
- LNTH 5.54
- MACD
- BRBR 0.23
- LNTH 0.34
- Stochastic Oscillator
- BRBR 78.12
- LNTH 85.89
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.